All In Biotech

Drug Trial Radar · NCT05275972

Descemet Endothelial Thickness Comparison Trial II

Descemet Endothelial Thickness Comparison Trials (DETECT I & II)

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

60

Actual

Start

Jan 23, 2023

Primary completion

Oct 30, 2027

Study completion Oct 30, 2028

Sponsor

Lead sponsor
Stanford UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Oregon Health and Science University; University of California, San Francisco; University of California, Davis; Case Western Reserve University; Dartmouth-Hitchcock Medical Center; University of Pennsylvania; University of Miami; Wills Eye Hospital; Devers Eye Institute
First posted
Mar 11, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.

Conditions

  • Fuchs
  • Fuchs Dystrophy
  • Fuchs' Endothelial Dystrophy

Interventions

  • RipasudilDrug

    Topical Ripasudil 0.4%

  • PlaceboDrug

    Topical Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best spectacle-corrected visual acuity (BSCVA)Time frame: 12 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

  • University of California Davis

    Sacramento, California

  • University of Miami

    Palm Beach Gardens, Florida

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • Legacy Devers Eye Institute

    Portland, Oregon

  • Oregon Health & Science University

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Wills Eye Hospital

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.